Pathways to the diagnosis of ovarian cancer in the UK: a cohort study in primary care
- PMID: 20121830
- DOI: 10.1111/j.1471-0528.2010.02499.x
Pathways to the diagnosis of ovarian cancer in the UK: a cohort study in primary care
Abstract
Objective: To identify the routes patients with ovarian cancer take between first symptom presentation and diagnosis.
Design: Cohort study.
Setting: The study took place in 39 general practices in Devon, UK.
Population: All ovarian cancer patients identified in the practices, with a diagnosis between 2000 and 2007 inclusive.
Methods: All patients had their cancer symptoms, referrals, and diagnoses identified and dated using their doctors' records.
Main outcome measures: Numbers of patients taking specific routes to diagnosis, together with the time taken to diagnosis.
Results: Three main routes to diagnosis emerged. The first was the expected route of outpatient referral: 195 (92% of the total) had at least one of the seven ovarian cancer symptoms or an abdominal mass. A total of 123 (58%) were referred to a specialist, although only 65 (31%) were referred to a gynaecologist. Thirty-five (17%) were initially investigated within primary care by ultrasound scanning, and a further 35 (17%) were admitted as emergencies. The interval from first symptom to referral was similar across the different pathways, with a median (interquartile range) time between the first symptom presenting to primary care and first investigation or referral being 2.5 (0, 27.5) days. The median interval from first symptom reported in primary care to diagnosis was 74.5 (32, 159) days.
Conclusions: Only a minority of ovarian cancer patients follow the expected route to diagnosis, of urgent referral to a gynaecologist. In most women, GPs rapidly identified the need to investigate. Avoidable delays generally occurred after the decision to investigate was made.
Comment in
-
Pathways to the diagnosis of ovarian cancer in the UK: a cohort study in primary care.BJOG. 2010 Jul;117(8):1033; author reply 1033-4. doi: 10.1111/j.1471-0528.2010.02587.x. BJOG. 2010. PMID: 20536437 No abstract available.
Similar articles
-
Pathways to the diagnosis of lung cancer in the UK: a cohort study.BMC Fam Pract. 2008 May 18;9:31. doi: 10.1186/1471-2296-9-31. BMC Fam Pract. 2008. PMID: 18485242 Free PMC article.
-
Time to diagnosis of Type I or II invasive epithelial ovarian cancers: a multicentre observational study using patient questionnaire and primary care records.BJOG. 2016 May;123(6):1012-20. doi: 10.1111/1471-0528.13447. Epub 2015 May 29. BJOG. 2016. PMID: 26032603 Free PMC article.
-
Feasibility of screening for ovarian cancer using symptoms as selection criteria.BJOG. 2007 Jan;114(1):59-64. doi: 10.1111/j.1471-0528.2006.01153.x. BJOG. 2007. PMID: 17233861 Clinical Trial.
-
Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.Health Technol Assess. 2005 Feb;9(3):iii-iv, 1-126. doi: 10.3310/hta9030. Health Technol Assess. 2005. PMID: 15694064 Review.
-
One-stop clinic for patients with suspected ovarian cancer: results from a retrospective outcome study of the referral pathway.BMC Womens Health. 2021 Dec 28;21(1):429. doi: 10.1186/s12905-021-01540-w. BMC Womens Health. 2021. PMID: 34961545 Free PMC article. Review.
Cited by
-
The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population.Cancers (Basel). 2022 Apr 24;14(9):2124. doi: 10.3390/cancers14092124. Cancers (Basel). 2022. PMID: 35565253 Free PMC article.
-
Diagnosis of cancer as an emergency: a critical review of current evidence.Nat Rev Clin Oncol. 2017 Jan;14(1):45-56. doi: 10.1038/nrclinonc.2016.155. Epub 2016 Oct 11. Nat Rev Clin Oncol. 2017. PMID: 27725680 Review.
-
Identifying Ovarian Cancer in Symptomatic Women: A Systematic Review of Clinical Tools.Cancers (Basel). 2020 Dec 8;12(12):3686. doi: 10.3390/cancers12123686. Cancers (Basel). 2020. PMID: 33302525 Free PMC article. Review.
-
Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).Gynecol Oncol. 2023 Dec;179:123-130. doi: 10.1016/j.ygyno.2023.11.005. Epub 2023 Nov 18. Gynecol Oncol. 2023. PMID: 37980767 Free PMC article. Clinical Trial.
-
Symptom interpretation and health care seeking in ovarian cancer.BMC Womens Health. 2011 Jun 23;11:31. doi: 10.1186/1472-6874-11-31. BMC Womens Health. 2011. PMID: 21699682 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical